Results 121 to 130 of about 5,277 (210)

Approche intégrée des maladies émergentes à transmission vectorielle et changements mondiaux : exemple et perspective [PDF]

, 2009
Vector-borne diseases (e.g., bluetongue or Rift Valley fever) are very sensitive to environmental changes. As such, they are excellent models to study disease emergence in a changing world, with more intense commercial exchanges, climate changes, and ...
Aumont, Gilles, De La Rocque, Stéphane, Gouro, Abdoulaye, Lancelot, Renaud   +3 more
core  

Genotypic differentiation and evolutionary dynamics of puumala orthohantavirus (PUUV)

Acta Virologica
Puumala orthohantavirus (PUUV) is a causative agent of haemorrhagic fever with renal syndrome, mainly transmitted through rodent excretions. Classification of PUUV has traditionally been based on the geographic locations of their discovery, but this ...
Mariia A. Dashian, Ilya A. Volkhin, Pavel Yu. Volchkov, Pavel Yu. Volchkov, Pavel Yu. Volchkov, Andrei A. Deviatkin, Andrei A. Deviatkin   +6 more
doaj   +1 more source

Macropinocytosis and Clathrin-Dependent Endocytosis Play Pivotal Roles for the Infectious Entry of Puumala Virus. [PDF]

J Virol, 2020
Bauherr S, Larsberg F, Petrich A, Sperber HS, Klose-Grzelka V, Luckner M, Azab W, Schade M, Höfer CT, Lehmann MJ, Witkowski PT, Krüger DH, Herrmann A, Schwarzer R.   +13 more
europepmc   +1 more source

Distribution of puumala virus in Sweden

, 1997
Puumala virus, belonging to the genus hantavirus, is the causative agent of nephropathia epidemica (NE), a relatively mild form of hemorrhagic fever with renal syndrome. Puumala virus occurs endemically in Central and Northern Europe and Western Russia.
openaire   +1 more source

Remodelling of P-bodies and the cytoskeleton by <i>Orthohantavirus puumalaense</i> (Puumala virus). [PDF]

J Gen Virol
Schwarzer-Sperber HS, Petrich A, Schade M, Nilson N, Chibrac-Ahad L, Lehmann MJ, Paulick K, Weiss S, Dluzak T, Bourquain D, Witkowski PT, Krüger DH, Herrmann A, Schwarzer R.   +13 more
europepmc   +1 more source

Cross-binding antibodies capable of neutralising diverse hantaviruses are produced in response to Puumala virus infection. [PDF]

EBioMedicine
Clark JJ, Hatzl S, Vasilev K, Andreata-Santos R, Yong JS, Mittler E, Kasikci E, Chandran K, Simon V, Krause R, Krammer F.   +10 more
europepmc   +1 more source

Genetic analysis implicates ERAP1 and HLA as risk factors for severe Puumala virus infection. [PDF]

Hum Mol Genet
Haapaniemi H, Strausz S, Tervi A, Jones SE, Kanerva M, FinnGen, Estonian Biobank Research Team, Abner E, Fors Connolly AM, Ollila HM.   +9 more
europepmc   +1 more source

Phase 1 clinical trial of Hantaan and Puumala virus DNA vaccines delivered by needle-free injection. [PDF]

NPJ Vaccines
Hooper JW, Kwilas SA, Josleyn M, Norris S, Hutter JN, Hamer M, Livezey J, Paolino K, Twomey P, Koren M, Keiser P, Moon JE, Nwaeze U, Koontz J, Ledesma-Feliciano C, Landry N, Wellington T.   +16 more
europepmc   +1 more source

Evaluation of Real-Time RT-PCR for Diagnostic Use in Detection of Puumala Virus. [PDF]

Viruses, 2019
Niskanen S, Jääskeläinen A, Vapalahti O, Sironen T.   +3 more
europepmc   +1 more source

Replication of Tula Hantavirus [PDF]

, 2004
Kukkonen, Sami
core